WRD enters the final week of August with its lending market at full stretch — availability has collapsed to 20%, the tightest reading in nearly a year, even as the stock itself inches higher.
The sharpest story this week is in the borrow market. Availability dropped from 34% to 20% in a single session on August 25, hitting its lowest point of the past 12 months (the 52-week floor is 18.95%). Every share in the lending pool is currently lent out — the lending book is completely maxed out. Cost to borrow has risen 33% on the week to 1.29%, its highest level in over a month. That said, the absolute fee remains modest: at roughly 1.3%, borrowing WRD is still cheap compared to genuinely squeezed names. Short interest itself is a shade under 3.9% of the free float — meaningful but not extreme — and slipped 0.7% on the week even as availability tightened. The apparent contradiction (fewer shorts, tighter borrow) likely reflects reduced lending supply rather than fresh short-side conviction.
Options positioning tells a calmer story. The put/call ratio of 0.175 is barely a whisker above its 20-day average of 0.167 — well within one standard deviation — and is a long way from the 52-week high of 0.481 reached earlier this year. That low ratio means call open interest heavily outweighs puts, suggesting options traders are not hedging aggressively despite the borrow tightness. The ORTEX short score of 63.2 is edging up — it was 60.7 on August 12 — but ranks in only the 9th percentile of the broader universe, meaning the short-side conviction here is still well below what many comparably positioned names carry.
The Street is constructive on WeRide in the abstract, but the data tells a complicated story. The mean analyst price target is around $11–$23 across the coverage initiated since the stock's late-2024 listing, but those initiations — from HSBC (March 2026, $11.40 Buy), BofA (December 2025, $12 Buy), Citi (September 2025, $15.50 Buy), and UBS (August 2025, $12 Buy) — all predate the stock's current $6.08 handle by a wide margin. No analyst has updated targets in the past six months, and the gap between consensus targets and current price reflects how far WRD has drifted since those initiations. The stock has recovered 14% on the month and 1.3% on the week, but it remains well off the levels at which most of the bullish cases were written. The price-to-book multiple has compressed sharply, down roughly 11% in the past 30 days, while the negative P/E and negative EV/EBITDA confirm this is still a pre-profit story where conventional valuation provides little anchor.
The ownership structure is worth noting. UBER holds nearly 6% of shares with no recent change, while Morgan Stanley Investment Management added 5.75 million shares in Q2, bringing its stake to 4.3%. That institutional buying from a recognized name runs against the grain of stale analyst targets and borrow pressure. The co-founders Xu Han and Yan Li collectively hold more than 8% of the company, and the register's largest single reported trade was a 5% shareholder buying $11.8 million worth of shares in late March at $2.49 — long before the recent recovery to $6.08.
The most recent earnings print on August 12 produced a 6% single-day drop and a further 4% slide over the following week — a pattern worth tracking as the next earnings event is pencilled in for late November. Between now and then, the number to watch is availability: if it dips below the 52-week floor of 18.95%, or if cost to borrow starts moving materially above 2%, the borrow dynamics would shift from "tight but manageable" to something more consequential for short-side positioning.
See the live data behind this article on ORTEX.
Open WRD on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
